These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 7332442)
21. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group. Agarwala SS; Neuberg D; Park Y; Kirkwood JM Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858 [TBL] [Abstract][Full Text] [Related]
22. [Current results with surgery and adjuvant chemotherapy in malignant melanoma]. Mechl Z; Kopecný J Arch Geschwulstforsch; 1986; 56(5):367-71. PubMed ID: 2429631 [TBL] [Abstract][Full Text] [Related]
24. [Immunotherapy of malignant melanomas]. Macher E Haematol Blood Transfus; 1978; 21():285-91. PubMed ID: 738638 [No Abstract] [Full Text] [Related]
25. Adjuvant combination immunotherapy (BCG and levamisole) in malignant melanoma. Dandapat MC; Mohapatra SK; Patra SK Indian J Cancer; 1985 Jun; 22(2):100-7. PubMed ID: 3842124 [No Abstract] [Full Text] [Related]
26. [Combined immunotherapy and cytostatic therapy in stage II and III malignant melanoma (proceedings)]. Rundenstam CM Lakartidningen; 1978 Dec; 75(49):4568-9. PubMed ID: 723339 [No Abstract] [Full Text] [Related]
27. Treatment of malignant skin tumours with oral administration of BCG in enteric-coated capsules. Ishihara K; Ikeda S; Arai E; Sawada T Dev Biol Stand; 1986; 58 ( Pt A)():465-74. PubMed ID: 3596050 [TBL] [Abstract][Full Text] [Related]
28. [Results of adjuvant therapy with the preparation Poly-a Poly-u in patients with malignant melanoma during a 10-year observation]. Pawlicki M; Jońca M; Krzemieniecki K; Zuchowska-Vogelgesang B Wiad Lek; 1993 Dec; 46(23-24):912-4. PubMed ID: 7900387 [TBL] [Abstract][Full Text] [Related]
29. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin. MacGregor AB; Falk RE; Landi S; Ambus U; Samuel ES; Langer B Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200 [TBL] [Abstract][Full Text] [Related]
30. [Experiences with immune BCG therapy of malignant melanoma]. Altmeyer P; Nödl F Dtsch Med Wochenschr; 1978 Jul; 103(30):1214. PubMed ID: 668562 [No Abstract] [Full Text] [Related]
33. BCG immunotherapy in previously treated malignant melanoma patients. Mujagić H; Kolarić K; Malenica B; Nola P Biomedicine; 1979 Jun; 30(2):95-102. PubMed ID: 476270 [TBL] [Abstract][Full Text] [Related]
34. Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities. Ariyan S; Kirkwood JM; Mitchell MS; Nordlund JJ; Lerner AB; Papac RJ Surgery; 1982 Sep; 92(3):459-63. PubMed ID: 7112396 [TBL] [Abstract][Full Text] [Related]
35. Immune response and non-specific immunotherapy in melanoma. El-Domeiri AA Ann R Coll Surg Engl; 1978 Mar; 60(2):117-20. PubMed ID: 637492 [TBL] [Abstract][Full Text] [Related]